Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel cofilin inhibitor for the treatment of hemorrhagic brain injury

May 23, 2022

EXG-001-307: a novel gene therapy for spinal muscular atrophy

May 23, 2022

ATH-1019 reduces pain in STZ-induced diabetic neuropathy

May 23, 2022

ORT-247 demonstrates efficacy in preclinical models of CMT and ALS

May 20, 2022

HDAC6 inhibitor CKD-510 shows promise for the treatment of CMT1A

May 20, 2022

Mount Sinai School of Medicine patents ATP6V1A gene expression enhancers

May 20, 2022

U.S. researchers present preclinical data on KU-596 in X-linked Charcot-Marie-Tooth disease

May 19, 2022

Palacky University describes neuroprotective cholestane derivatives

May 18, 2022

Intrathalamic administration of AVB.PGRN rescues pathology in Grn-null FTD mice

May 17, 2022

SHP-2 inhibitor NSC-87877 ameliorates clinical symptoms of MuSK-induced myasthenia gravis

May 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...